Article
A clinical and pathological update on hepatocellular carcinoma
30 Mar 2022
Abstract excerpt
It is estimated that more than 1 million individuals will be affected annually by hepatocellular carcinoma (HCC) by 2025. HCC can be broadly grouped into two major molecular subgroups, each of which is characterized by specific morphological and phenotypic features that mirror the genetic background. The use of these tissue biomarkers in the daily practice of pathologists promises to better allocate patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
